Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (300760) — Capital Reinvestment Ratio
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (300760) has a Capital Reinvestment Ratio of 0.15x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥3.35 Billion) in capital expenditures (CN¥510.20 Million). Check 300760 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A Capital Reinvestment Ratio (2014–2024)
This chart tracks Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see Shenzhen Mindray Bio-Medical Electronics cash conversion from operations.
Annual Capital Reinvestment Ratio for Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A (2014–2024)
Year-by-year Capital Reinvestment Ratio for Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A from 2014 to 2024. See 300760 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.16x | CN¥12.43 Billion | CN¥1.96 Billion | ▼ -35.2% |
| 2023 | 0.24x | CN¥11.06 Billion | CN¥2.69 Billion | ▲ +54.1% |
| 2022 | 0.16x | CN¥12.14 Billion | CN¥1.92 Billion | ▲ +1.2% |
| 2021 | 0.16x | CN¥9.00 Billion | CN¥1.40 Billion | ▲ +16.9% |
| 2020 | 0.13x | CN¥8.87 Billion | CN¥1.18 Billion | ▼ -19.0% |
| 2019 | 0.16x | CN¥4.72 Billion | CN¥776.86 Million | ▼ -2.1% |
| 2018 | 0.17x | CN¥4.03 Billion | CN¥678.28 Million | ▲ +18.9% |
| 2017 | 0.14x | CN¥3.30 Billion | CN¥466.73 Million | ▲ +3.9% |
| 2016 | 0.14x | CN¥3.04 Billion | CN¥413.54 Million | ▼ -53.8% |
| 2015 | 0.29x | CN¥2.02 Billion | CN¥595.41 Million | ▼ -12.9% |
| 2014 | 0.34x | CN¥1.74 Billion | CN¥588.44 Million | — |